We meet Dallas Webb of BB Biotech (SWIX:BION) to talk about the biotech sector and what investors should look out for when picking biotech firms for their portfolio.\n\nGet our free daily newsletter on market movers at www.thearmchairtrader.com\n\nIf there are companies you would like the Armchair Trader to feature in future episodes reach us on www.thearmchairtrader.com\n\n0:52 Introduction to BB Biotech\n3:10 Is it important for biotech money managers to have biotech training?\n3:58 Dallas covers neurological disease, gene therapy and AI trends\n7:03 What are clinical holds?\n9:02 What size and type of company do BB Biotech look out for?\n11:55 Managing risk when investing in small companies\n14:37 Is there much IPO activity in the biotech sector?\n16:28 How will the sector weather current market volatility?\n19:14 The effect of rising inflation and interest rates on biotech firms\n20:54 Is it mostly specialists investing in biotech?\n24:06 BB Biotech's position on Moderna\n25:52 The platforms and pipelines for investable biotech firms